Sivik Global Healthcare’s McKesson MCK Stock Holding History

Sivik Global Healthcare’s Portfolio MCK Stock Details MCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.46M	Hold	4,000	–	–	2.63%	19
2026 Q1	$3.46M	Sell	4,000 -5,000	-56%	-$4.46M	2.63%	19
2025 Q4	$7.38M	Buy	9,000 +2,000	+29%	+$1.63M	2.14%	12
2025 Q3	$5.41M	Sell	7,000 -6,000	-46%	-$4.23M	1.57%	25
2025 Q2	$9.53M	Buy	13,000 +2,000	+18%	+$1.41M	2.59%	12
2025 Q1	$7.4M	Sell	11,000 -4,000	-27%	-$2.47M	4%	6
2024 Q4	$8.55M	Sell	15,000 -5,000	-25%	-$2.8M	4.5%	4
2024 Q3	$9.89M	Buy	20,000 +2,000	+11%	+$1.11M	4.19%	6
2024 Q2	$10.5M	Buy	18,000 +3,500	+24%	+$1.95M	3.78%	4
2024 Q1	$7.78M	Sell	14,500 -500	-3%	-$254K	1.82%	10
2023 Q4	$6.95M	Sell	15,000 -2,500	-14%	-$1.14M	2.9%	11
2023 Q3	$7.61M	Hold	17,500	–	–	3.85%	8
2023 Q2	$7.48M	Buy	17,500 +2,500	+17%	+$961K	1.75%	17
2023 Q1	$5.34M	Hold	15,000	–	–	2.3%	22
2022 Q4	$5.63M	Sell	15,000 -2,500	-14%	-$932K	2.65%	18
2022 Q3	$5.95M	Sell	17,500 -5,000	-22%	-$1.74M	3.31%	13
2022 Q2	$7.34M	Hold	22,500	–	–	4.17%	2
2022 Q1	$6.89M	Sell	22,500 -12,500	-36%	-$3.4M	2.84%	9
2021 Q4	$8.7M	Sell	35,000 -10,000	-22%	-$2.2M	3.73%	3
2021 Q3	$8.97M	Buy	45,000 +5,000	+13%	+$1,000K	2.14%	13
2021 Q2	$7.65M	Buy	40,000 +10,000	+33%	+$1.93M	1.49%	18
2021 Q1	$5.85M	Sell	30,000 -25,000	-45%	-$4.56M	2.13%	26
2020 Q4	$9.57M	Buy	55,000 +2,500	+5%	+$416K	3.9%	4
2020 Q3	$7.82M	Buy	52,500 +20,000	+62%	+$3.04M	3.36%	9
2020 Q2	$11.8M	Hold	32,500	–	–	3.9%	3
2020 Q1	$9.22M	Buy	+32,500	New	+$4.76M	3.64%	8
2019 Q1	–	Sell	-15,000	Closed	-$1.66M	–	63
2018 Q4	$1.66M	Sell	15,000 -7,500	-33%	-$935K	0.89%	39
2018 Q3	$2.98M	Sell	22,500 -12,500	-36%	-$1.63M	1.07%	41
2018 Q2	$4.67M	Buy	35,000 +17,813	+104%	+$2.61M	1.8%	26
2018 Q1	$2.42M	Sell	17,187 -12,813	-43%	-$2M	1.13%	38
2017 Q4	$4.68M	Buy	30,000 +5,000	+20%	+$741K	1.74%	25
2017 Q3	$3.84M	Sell	25,000 -5,000	-17%	-$780K	1.31%	30
2017 Q2	$4.94M	Hold	30,000	–	–	1.81%	21
2017 Q1	$4.45M	Sell	30,000 -5,000	-14%	-$732K	2.07%	22
2016 Q4	$4.92M	Buy	+35,000	New	+$5.15M	2.35%	19
2016 Q2	–	Sell	-51,000	Closed	-$8.02M	–	61
2016 Q1	$8.02M	Buy	51,000 +26,000	+104%	+$4.2M	3.55%	5
2015 Q4	$4.93M	Sell	25,000 -20,000	-44%	-$3.78M	2.34%	14
2015 Q3	$8.33M	Buy	45,000 +19,273	+75%	+$4.08M	4.04%	5
2015 Q2	$5.78M	Sell	25,727 -9,273	-26%	-$2.14M	2.01%	15
2015 Q1	$7.92M	Buy	35,000 +300	+0.9%	+$66.5K	2.69%	4
2014 Q4	$7.2M	Buy	34,700 +9,700	+39%	+$1.97M	2.92%	5
2014 Q3	$4.87M	Sell	25,000 -5,000	-17%	-$962K	2.21%	13
2014 Q2	$5.59M	Buy	30,000 +10,160	+51%	+$1.81M	2.82%	5
2014 Q1	$3.5M	Buy	19,840 +1,840	+10%	+$322K	2.19%	9
2013 Q4	$2.9M	Buy	+18,000	New	+$2.76M	2.06%	19

Other funds holding MCK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

JHP

James Hambro & Partners London, United Kingdom $2.76B AUM 19.67% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sivik Global Healthcare's MCK Position: Q2 2026 in Review

Sivik Global Healthcare held its McKesson (MCK) position steady in Q2 2026 at 4,000 shares worth $3.46M. The position accounts for 2.63% of the portfolio, ranked #19.

Sivik Global Healthcare first reported a position in MCK in Q4 2013 and has held it in 45 quarters since. The position peaked at $11.8M in Q2 2020. 835 funds tracked by Wall St. Rank hold MCK as of Q2 2026.

Sivik Global Healthcare held 4,000 shares of McKesson worth $3.46M as of Q2 2026.
Sivik Global Healthcare left its McKesson share count unchanged in Q2 2026.
McKesson made up 2.63% of Sivik Global Healthcare's portfolio in Q2 2026, its #19 holding.
Sivik Global Healthcare first reported a position in McKesson in Q4 2013 and has held it in 45 quarters since.
Sivik Global Healthcare's McKesson position peaked at $11.8M in Q2 2020.
835 funds tracked by Wall St. Rank held McKesson as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.